Initial Therapeutics
Biotechnology Research
South San Francisco, California, United States
20 employees
- Employees
- 20
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Initial Therapeutics Overview
- Headquarters
- South San Francisco, California, United States
- Website
- initialtx.com
- Industry
- Biotechnology Research
- Employees
- 20
- Founded
- 2020
- Funding
- 75.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Initial Therapeutics
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages. Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
Initial Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Initial Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Peter Dilaura | Biotech CEO, Board Member, Company | San Francisco, California, United States |
Email
Phone
|
| Daniel Pierce |
View
|
||
| Phillip A. Patten, Phd | Biotechnology Consultant | San Francisco Bay Area, United States |
Email
|
| Sarah Smith | Virtual Assistant - 15+ Yrs Executive | Port Orange, Florida, United States |
View
|
Employees by Management Level
Executive
1 profile
Individual contributor
1 profile
Associate / junior
1 profile
Compare Similar Companies to Initial Therapeutics
Maze Therapeutics
Biotechnology Research
Ascidian Therapeutics
Biotechnology
Juvena Therapeutics
Biotechnology Research
Rezo Therapeutics
Biotechnology Research
Bitterroot Bio
Biotechnology Research
ATP (Apple Tree Partners)
Venture Capital And Private Equity Principals
Deep Apple Therapeutics
Biotechnology Research
Evercrisp Biosciences
Biotechnology Research
Nine Square Therapeutics
Biotechnology
Apertor Pharmaceuticals
Biotechnology Research